Goodwin has advised ]init[ AG, a portfolio company of Rivean Capital (“Rivean Capital”) and EMERAM Capital Partners (“EMERAM”), on the financing of the acquisition of HBSN Group (“HBSN”).
Headquartered in Berlin, Germany, ]init[ is a leading German IT services provider focusing on digitization projects in the public sector as well as in the regulated private sector. The company’s end-to-end services offering covers strategy and consulting, experience and content, platform and application development, as well as managed services and operations. The group operates in Germany, Belgium Switzerland and Portugal and has more than 1,400 employees.
Over the past 18 years, HBSN Group has developed into a successful consulting and technology business in the healthcare market. The company supports university hospitals and clinics, private and statutory health insurers, medical services, public health authorities, and IT system providers in software development, IT operations, and transformation projects.
Rivean Capital is a leading European private equity investor in mid-market transactions with operations in the Benelux, DACH region, and Italy. With offices in Frankfurt, Amsterdam, Brussels, Zug and Milan, funds advised by Rivean Capital manage more than €5bn in assets. Since its inception in 1982, Rivean Capital has supported more than 250 companies to achieve their growth ambitions and has a strong track record of supporting and scaling successful businesses with cross-border growth agendas, including footprint expansions and operational excellence trajectories.
EMERAM is one of the leading investment managers for investments in mid-sized companies in the German-speaking region. The funds advised by EMERAM provide more than 800 million euros in capital for the development of growth companies. Its investment strategy focuses on digital transformation, health and wellbeing, as well as the energy transition.
The Goodwin’s transaction team was led by partners Winfried M. Carli and Folko Moroni and included associate Daniel Wagner as well as transaction lawyer Rina Omura (Private Equity/Finance, Munich).